AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17549054 — intervention group
Group type: COMPARATOR
Intervention: Combined results from no FFP group
Number of subjects: 43
Study 17549054 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall results
Number of subjects: 43
Study 10879067 — intervention group
Group type: EXPERIMENTAL
Intervention: Various treatments for atherosclerosis; specific interventions not detailed in the abstract.
Number of subjects: 0
Study 10879067 — intervention group
Group type: COMPARATOR
Intervention: Not applicable; control group not specified.
Number of subjects: 0
Study 9075448 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholesterol-lowering intervention (Food for Heart Program)
Number of subjects: 372
Study 9075448 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 372
Study 8445289 — intervention group
Group type: EXPERIMENTAL
Intervention: Thromboxane synthase inhibitor (FCE 22178, 400 mg two or three times per day)
Number of subjects: 15
Study 8445289 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 3021497 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium
Number of subjects: 15
Study 3021497 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate
Number of subjects: 15
Study 3021497 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 29174274 — intervention group
Group type: EXPERIMENTAL
Intervention: Placentophagy (encapsulated placenta)
Number of subjects: 27
Study 29174274 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 27230770 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month family intervention to reduce screen time
Number of subjects: 251
Study 27230770 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary caregiver intervention use
Number of subjects: 251
Study 27230770 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention delivery by community workers
Number of subjects: 251
Study 25095797 — intervention group
Group type: EXPERIMENTAL
Intervention: Client-centred health promotion intervention (eight telephone health promotion sessions)
Number of subjects: 300
Study 25095797 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 300
Study 25095797 — intervention group
Group type: EXPERIMENTAL
Intervention: Client-centred health promotion intervention
Number of subjects: 300
Study 23579561 — intervention group
Group type: EXPERIMENTAL
Intervention: Reaching training in supine
Number of subjects: 24
Study 23579561 — intervention group
Group type: EXPERIMENTAL
Intervention: Reaching training in reclined
Number of subjects: 24
Study 23579561 — intervention group
Group type: COMPARATOR
Intervention: No training (Control)
Number of subjects: 24
Study 20176355 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate sheath removal and early ambulation (Intervention Group, n=172)
Number of subjects: 347
Study 20176355 — intervention group
Group type: COMPARATOR
Intervention: Standard care with sheath removal after 4h and additional 6h of rest (Control Group, n=175)
Number of subjects: 347
Study 17323092 — intervention group
Group type: EXPERIMENTAL
Intervention: Ponseti's method
Number of subjects: 45
Study 17323092 — intervention group
Group type: COMPARATOR
Intervention: Kite's method
Number of subjects: 45
Study 16356945 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice nurse led partner notification
Number of subjects: 140
Study 16356945 — intervention group
Group type: COMPARATOR
Intervention: Referral to a genitourinary medicine clinic
Number of subjects: 140
Study 12792342 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (n = 11)
Number of subjects: 24
Study 12792342 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 13)
Number of subjects: 24
Study 10799728 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-mastectomy irradiation plus systemic treatment
Number of subjects: 17
Study 10799728 — intervention group
Group type: COMPARATOR
Intervention: Systemic treatment alone
Number of subjects: 17
Study 8970246 — intervention group
Group type: EXPERIMENTAL
Intervention: Brimonidine 0.2%
Number of subjects: 186
Study 8970246 — intervention group
Group type: EXPERIMENTAL
Intervention: Brimonidine 0.5%
Number of subjects: 186
Study 8970246 — intervention group
Group type: EXPERIMENTAL
Intervention: Brimonidine 0.5% (one drop preoperatively, postoperatively or both)
Number of subjects: 186
Study 8970246 — intervention group
Group type: COMPARATOR
Intervention: Brimonidine 0.2% twice daily
Number of subjects: 186
Study 8970246 — intervention group
Group type: COMPARATOR
Intervention: Brimonidine 0.2% three times daily
Number of subjects: 186
Study 1503059 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc-fortified formula
Number of subjects: 39
Study 1503059 — intervention group
Group type: COMPARATOR
Intervention: Non-supplemented formula (Control)
Number of subjects: 39
Study 29569405 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 334
Study 29569405 — intervention group
Group type: COMPARATOR
Intervention: No Digoxin (Control)
Number of subjects: 334
Study 27513397 — intervention group
Group type: EXPERIMENTAL
Intervention: Seawater (2.3%) nasal drops
Number of subjects: 109
Study 27513397 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline (0.9%) nasal drops
Number of subjects: 109
Study 27513397 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nasal drops)
Number of subjects: 109
Study 25464511 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute stress via Trier social stress test (TSST)
Number of subjects: 22
Study 25464511 — intervention group
Group type: COMPARATOR
Intervention: Baseline measurements
Number of subjects: 22
Study 22386762 — intervention group
Group type: EXPERIMENTAL
Intervention: LR-Accu-Vit
Number of subjects: 242
Study 22386762 — intervention group
Group type: COMPARATOR
Intervention: LR-fresh
Number of subjects: 242
Study 19697094 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy group (IPT-G)
Number of subjects: 50
Study 19697094 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 50
Study 18241525 — intervention group
Group type: EXPERIMENTAL
Intervention: Human thrombin
Number of subjects: 305
Study 18241525 — intervention group
Group type: COMPARATOR
Intervention: Bovine thrombin
Number of subjects: 305
Study 17242805 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine 600 mg
Number of subjects: 54
Study 17242805 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 12809451 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning insulin glargine + 3 mg glimepiride
Number of subjects: 695
Study 12809451 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedtime insulin glargine + 3 mg glimepiride
Number of subjects: 695
Study 12809451 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedtime NPH insulin + 3 mg glimepiride
Number of subjects: 695
Study 12809451 — intervention group
Group type: COMPARATOR
Intervention: Morning insulin glargine
Number of subjects: 695
Study 12809451 — intervention group
Group type: COMPARATOR
Intervention: Bedtime NPH insulin
Number of subjects: 695
Study 12809451 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedtime insulin glargine
Number of subjects: 695
Study 10810461 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment protocols for osteosarcoma (same as used for adolescents)
Number of subjects: 30
Study 10810461 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment protocols for osteosarcoma
Number of subjects: 30
Study 8861695 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading dose of 10 mg/kg of phenytoin (group A, n = 10)
Number of subjects: 20
Study 8861695 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading dose of 15 mg/kg of phenytoin (group B, n = 10)
Number of subjects: 20
Study 8861695 — intervention group
Group type: EXPERIMENTAL
Intervention: PHT maintenance treatment (250 mg, i.v., every 8 hours)
Number of subjects: 20
Study 1739172 — intervention group
Group type: EXPERIMENTAL
Intervention: rIFN-gamma (100 micrograms) subcutaneously each day for 10 days
Number of subjects: 213
Study 1739172 — intervention group
Group type: EXPERIMENTAL
Intervention: rIFN-gamma
Number of subjects: 213
Study 1739172 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study 6519156 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine 25 mg
Number of subjects: 12
Study 6519156 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine 50 mg
Number of subjects: 12
Study 6519156 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine 100 mg
Number of subjects: 12
Study 6519156 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30699315 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antibiotics
Number of subjects: 1054
Study 30699315 — intervention group
Group type: COMPARATOR
Intervention: Intravenous antibiotics
Number of subjects: 1054
Study 30130674 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 755
Study 30130674 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 755
Study 27387676 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined radiochemotherapy and tumor resection
Number of subjects: 50
Study 27387676 — intervention group
Group type: EXPERIMENTAL
Intervention: Solely radiochemotherapy
Number of subjects: 50
Study 27387676 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy followed by tumor resection
Number of subjects: 50
Study 27387676 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy only
Number of subjects: 50
Study 27387676 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival (OS)
Number of subjects: 50
Study 27387676 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall event-free survival (ES)
Number of subjects: 50
Study 27387676 — intervention group
Group type: EXPERIMENTAL
Intervention: Bladder preservation rate
Number of subjects: 50
Study 24203264 — intervention group
Group type: EXPERIMENTAL
Intervention: E-O technique
Number of subjects: 100
Study 24203264 — intervention group
Group type: COMPARATOR
Intervention: E-C technique
Number of subjects: 100
Study 22124712 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin administration prior to EEG recording
Number of subjects: 50
Study 22124712 — intervention group
Group type: COMPARATOR
Intervention: No melatonin administration prior to EEG recording
Number of subjects: 50
Study 22124712 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (with and without melatonin)
Number of subjects: 50
Study 19247575 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise group (EG)
Number of subjects: 71
Study 19247575 — intervention group
Group type: COMPARATOR
Intervention: No-exercise group (no-EG)
Number of subjects: 71
Study 18727656 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus salivarius WB21 (6.7 x 10(8) CFU) with xylitol, three times a day for 8 weeks
Number of subjects: 66
Study 18727656 — intervention group
Group type: COMPARATOR
Intervention: Placebo (xylitol alone), three times a day for 8 weeks
Number of subjects: 66
Study 16198658 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine 100 mg
Number of subjects: 12
Study 11967035 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound screening of kidneys in newborns
Number of subjects: 4000
Study 11967035 — intervention group
Group type: EXPERIMENTAL
Intervention: Second ultrasound scanning at one month of age
Number of subjects: 4000
Study 11967035 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up ultrasound studies
Number of subjects: 4000
Study 10439743 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine (0.07 mg/kg) with glycopyrrolate (0.01 mg/kg) given 5 min after relaxant
Number of subjects: 160
Study 10439743 — intervention group
Group type: COMPARATOR
Intervention: Control (no neostigmine)
Number of subjects: 160
Study 10439743 — intervention group
Group type: EXPERIMENTAL
Intervention: Succinylcholine (1.5 mg/kg)
Number of subjects: 160
Study 7557093 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 28
Study 7557093 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin + Propranolol
Number of subjects: 28
Study 7557093 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin + Furosemide
Number of subjects: 28
Study 7557093 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 2112346 — intervention group
Group type: EXPERIMENTAL
Intervention: Packed red blood cells (AS-1)
Number of subjects: 20
Study 2112346 — intervention group
Group type: COMPARATOR
Intervention: Washed red blood cells
Number of subjects: 20
Study 38439 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice (amounts: 150, 180, 210, 240 ml) ingested with each meal during a 12-day period.
Number of subjects: 40
Study 38439 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cranberry juice) during the first 6 days of the study.
Number of subjects: 40
Study 31172201 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of cooked potatoes, oatmeal, corn flakes, cereals, pasta, and rice
Number of subjects: 2523
Study 31172201 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of cooked potatoes
Number of subjects: 2523
Study 31172201 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette consumption
Number of subjects: 2523
Study 31172201 — intervention group
Group type: EXPERIMENTAL
Intervention: Psoriasis, allergic rhinitis, and atopic dermatitis
Number of subjects: 2523
Study 28758155 — intervention group
Group type: EXPERIMENTAL
Intervention: APOL1 renal-risk variants (RRVs)
Number of subjects: 2568
Study 25886499 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education + 12-week supervised exercise therapy program
Number of subjects: 45
Study 25886499 — intervention group
Group type: COMPARATOR
Intervention: Patient education only
Number of subjects: 45
Study 23692624 — intervention group
Group type: EXPERIMENTAL
Intervention: Nylon cuff (5 × 83 cm)
Number of subjects: 0
Study 23692624 — intervention group
Group type: COMPARATOR
Intervention: Elastic cuff (5 × 135 cm)
Number of subjects: 0
Study 21382953 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed education (textbook, instructional video, portable equipment kit, 90-minute simulation)
Number of subjects: 46
Study 21382953 — intervention group
Group type: COMPARATOR
Intervention: Traditional class (6 hours of lectures and instructor-directed skill stations)
Number of subjects: 46
Study 19594771 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 1706
Study 19594771 — intervention group
Group type: COMPARATOR
Intervention: Control (non-statin treatment)
Number of subjects: 1706
Study 17301206 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of guidelines for the management of patients with atrial fibrillation and TIA using a multifaceted approach including evidence‐based recommendations, audit and feedback, interactive educational sessions, patient prompts and outreach visits.
Number of subjects: 76
Study 17301206 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of guidelines for the management of patients with atrial fibrillation and TIA.
Number of subjects: 76
Study 15697105 — intervention group
Group type: EXPERIMENTAL
Intervention: 35 microg Ethinylestradiol/2 mg Cyproterone Acetate (Diane 35, Schering) for 3 months
Number of subjects: 31
Study 15697105 — intervention group
Group type: COMPARATOR
Intervention: 10 mg Medroxyprogesterone Acetate (MPA) x 10 days every month for 3 months (control group)
Number of subjects: 31
Study 12172440 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose low molecular weight heparin (LMWH) Certoparin, 2 x 8000 aXa IU
Number of subjects: 0
Study 9596473 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholera vaccine 1
Number of subjects: 0
Study 9596473 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholera vaccine 2
Number of subjects: 0
Study 9596473 — intervention group
Group type: COMPARATOR
Intervention: Unvaccinated control group
Number of subjects: 0
Study 7577315 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE-inhibitors
Number of subjects: 0
Study 2539763 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinapril (10, 20, and 40 mg/day)
Number of subjects: 0
Study 2539763 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (10, 20, and 40 mg/day)
Number of subjects: 0
Study 2539763 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinapril with hydrochlorothiazide
Number of subjects: 0
Study 2539763 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinapril and Enalapril
Number of subjects: 0
Study 81154 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 1200 mg daily
Number of subjects: 30
Study 81154 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac 75 mg daily
Number of subjects: 30
Study 31957686 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Care + Brief Motivational Intervention (SC+BMI)
Number of subjects: 43
Study 31957686 — intervention group
Group type: COMPARATOR
Intervention: Standard Care Alone (SC)
Number of subjects: 43
Study 31058457 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring urinary salt excretion measurement device for 4 weeks
Number of subjects: 100
Study 31058457 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study 28550914 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-drilling screws (SDS)
Number of subjects: 49
Study 28550914 — intervention group
Group type: COMPARATOR
Intervention: Self-tapping screws (STS)
Number of subjects: 49
Study 25909530 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 19
Study 23218853 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroprusside gel (10 mg, 1 mL)
Number of subjects: 24
Study 23218853 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 24
Study 23218853 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroprusside gel
Number of subjects: 24
Study 23218853 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study 21787498 — intervention group
Group type: EXPERIMENTAL
Intervention: Resilon (RealSeal system)
Number of subjects: 80
Study 21787498 — intervention group
Group type: COMPARATOR
Intervention: Gutta‐percha (with AH Plus sealer)
Number of subjects: 80
Study 21787498 — intervention group
Group type: COMPARATOR
Intervention: Negative control group (unfilled specimens)
Number of subjects: 80
Study 21787498 — intervention group
Group type: COMPARATOR
Intervention: Positive control group (flowable, dual‐cure composite resin)
Number of subjects: 80
Study 19458363 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention (coronary angiography < or = 24 hours after randomization)
Number of subjects: 3031
Study 19458363 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention (coronary angiography > or = 36 hours after randomization)
Number of subjects: 3031
Study 19458363 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention in high-risk patients
Number of subjects: 3031
Study 19458363 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention in low-to-intermediate risk patients
Number of subjects: 3031
Study 16731317 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler ultrasound (SonoGuide2 with a 5.0‐MHz probe)
Number of subjects: 338
Study 16731317 — intervention group
Group type: COMPARATOR
Intervention: B-mode ultrasound (SiteRite II ultrasound system with a 7.5‐MHz transducer)
Number of subjects: 338
Study 16731317 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler ultrasound
Number of subjects: 338
Study 16731317 — intervention group
Group type: COMPARATOR
Intervention: B-mode ultrasound
Number of subjects: 338
Study 15308353 — intervention group
Group type: EXPERIMENTAL
Intervention: Men D (2 doses at 3 and 9 months)
Number of subjects: 618
Study 15308353 — intervention group
Group type: COMPARATOR
Intervention: Men PS (at 24 months)
Number of subjects: 618
Study 15308353 — intervention group
Group type: EXPERIMENTAL
Intervention: Men D (single dose in infancy)
Number of subjects: 618
Study 15308353 — intervention group
Group type: EXPERIMENTAL
Intervention: Men D
Number of subjects: 618
Study 15308353 — intervention group
Group type: COMPARATOR
Intervention: Men PS
Number of subjects: 618
Study 10958046 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 1200 mg/day (400 mg/day from 1st to 3rd day, 800 mg/day from 4th to 6th day, 1200 mg/day from 7th day)
Number of subjects: 63
Study 10958046 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 63
Study 10958046 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group not explicitly detailed)
Number of subjects: 63
Study 8623963 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg IV ephedrine
Number of subjects: 110
Study 8623963 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg IV ephedrine
Number of subjects: 110
Study 8623963 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 110
Study 1836780 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole 2% emulsion
Number of subjects: 50
Study 1836780 — intervention group
Group type: COMPARATOR
Intervention: Placebo (same emulsion without active drug)
Number of subjects: 50
Study 6122755 — intervention group
Group type: EXPERIMENTAL
Intervention: Intestinal lavage with 18 L of normal saline administered via a jejunal tube over a period of 2 hours
Number of subjects: 6
Study 6122755 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving similar treatment without lavage
Number of subjects: 6
Study 31535519 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-based sealant
Number of subjects: 10
Study 31535519 — intervention group
Group type: COMPARATOR
Intervention: Resin modified glass ionomer-based sealant
Number of subjects: 10
Study 28822828 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (25mg/d)
Number of subjects: 308
Study 28822828 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 308
Study 26720458 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein (10 mg) and antioxidant supplement
Number of subjects: 79
Study 26720458 — intervention group
Group type: COMPARATOR
Intervention: Lutein and antioxidant supplement in combination with PUFA
Number of subjects: 79
Study 24617431 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (7.5 mg weekly)
Number of subjects: 40